Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ian W. Tattersall"'
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 718-721 (2024)
Abstract Erdheim–Chester disease (ECD) is a rare, non‐Langerhans histiocytic disease, with the manifestation of cutaneous lesions becoming further recognised and understood. Most commonly presenting with xanthelasma‐like lesions, cutaneous mani
Externí odkaz:
https://doaj.org/article/e12565dfc7294d0e9c8b6c49cf537c9e
Autor:
Vignesh Ramachandran, Efe Kakpovbia, Michelle C. Juarez, Neil Jairath, Andjela Nemcevic, Christine C. Akoh, Ian M. Ahearn, Ian W. Tattersall, Nayoung Lee, Jo-Ann M. Latkowski, John G. Zampella
Publikováno v:
Military Medical Research, Vol 11, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/64f02f7e99e14fb4bd756417539c3d92
Autor:
Fatima Bawany, MD, Vignesh Ramachandran, MD, Eduardo Rodriguez, MD, Randie H. Kim, MD, Jeffrey S. Weber, MD, Ian W. Tattersall, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 41, Iss , Pp 7-9 (2023)
Externí odkaz:
https://doaj.org/article/571264ec4a364c9d915d6f844ff0e527
Autor:
Christina S. Oh, BA, Michael J. Martinez, BS, Shane Meehan, MD, Daniel Gutierrez, MD, Ian W. Tattersall, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 35, Iss , Pp 28-32 (2023)
Externí odkaz:
https://doaj.org/article/9fe64ee15bdd463cb1dc8ebada9ac48e
Autor:
Duy C. Tran, MD, Maria Karim, BA, Kristen Lo Sicco, MD, Nooshin Brinster, MD, Emily C. Milam, MD, Ian W. Tattersall, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 24, Iss , Pp 97-100 (2022)
Externí odkaz:
https://doaj.org/article/6f9564cd50a54717a95b93b6ed8735c2
Autor:
Fatima N. Mirza, MPH, Ian W. Tattersall, MD, PhD, Anitha Kamath Rao, MD, Kathleen C. Suozzi, MD, Mariam B. Totonchy, MD
Publikováno v:
JAAD Case Reports, Vol 23, Iss , Pp 109-111 (2022)
Externí odkaz:
https://doaj.org/article/b754d13bdf9f43ca964c73f4362c3aee
Autor:
Jan Kitajewski, Carrie J. Shawber, Paul E. Rosenstiel, Ian W. Tattersall, Reyhaan A. Chaudhri, Henar Cuervo, Natalie M. Kofler, Aino Murtomaki, Thaned Kangsamaksin
Figure S1 shows that N11-13 decoy blocks activation of Notch1 by DLL1 but not JAG2 whereas N110-24 decoy blocks activation of Notch1 by JAG2 but not DLL1. Figure S2 shows that purified N11-13 decoy preferentially inhibited DLL4-mediated Notch1 activa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0d13f9b240b3711be0d4a353728e4e9
https://doi.org/10.1158/2159-8290.22529541
https://doi.org/10.1158/2159-8290.22529541
Autor:
Juhi M. Purswani, Zahna Bigham, Prince Adotama, Cheongeun Oh, Julie Xiao, Olivier Maisonet, Jose R. Teruel, Daniel Gutierrez, Ian W. Tattersall, Carmen A. Perez, Naamit K. Gerber
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a0a799064fdb752d67d4c43510cc233
https://doi.org/10.1016/j.ijrobp.2023.04.006
https://doi.org/10.1016/j.ijrobp.2023.04.006
Autor:
Juhi M. Purswani, Christy Nwankwo, Prince Adotama, Daniel Gutierrez, Carmen A. Perez, Ian W. Tattersall, Naamit K. Gerber
Publikováno v:
Clinical breast cancer. 23(1)
The purpose of this study is to systematically review data pertaining to breast cancer and radiation-induced skin reactions in patients with skin of color (SOC), as well as data pertaining to objective measurements of skin pigmentation in the assessm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327ede21a928a95e0325a8905a8d0881
https://pubmed.ncbi.nlm.nih.gov/36335037
https://pubmed.ncbi.nlm.nih.gov/36335037
Publikováno v:
Clinics in Dermatology. 38:660-678
The development of immunotherapy has led to a paradigm shift in the treatment of both solid and hematologic malignancies. As immunomodulatory therapies are employed with increasing frequency, a greater number of immune-related adverse reactions are b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3aed661e081db8c6c5d1d21091aa230
https://doi.org/10.1016/j.clindermatol.2020.06.011
https://doi.org/10.1016/j.clindermatol.2020.06.011